SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Transcept Pharmaceuticals, Inc. Comments on New FDA Dosage Reduction Requirements for Zolpidem Based Prescription Sleep Aids Administered at Bedtime